SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Consensus price target: $40.00 (+1559.75% upside from $2.41)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Opaleye Management Inc. 10 percent owner | Apr 29, 2026 | Sale | 1,000 | $17.25K |
| Opaleye Management Inc. 10 percent owner | Apr 29, 2026 | Sale | 23,360 | $402.9K |
| Opaleye Management Inc. 10 percent owner | Apr 28, 2026 | Sale | 2,500 | $46.17K |
| Opaleye Management Inc. 10 percent owner | Apr 28, 2026 | Sale | 43,788 | $808.65K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $44.05M | +34.98% | $11.81M |
| 2024 | $32.63M | +59.99% | $-31.37M |
| 2023 | $20.4M | +21.84% | $-25.81M |
Stock data for SNWV: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics